These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19931329)

  • 1. Structural and chemical aspects of HPMA copolymers as drug carriers.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2010 Feb; 62(2):150-66. PubMed ID: 19931329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives of HPMA-based copolymers derived by post-polymerization modification.
    Nuhn L; Barz M; Zentel R
    Macromol Biosci; 2014 May; 14(5):607-18. PubMed ID: 24644097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
    Lu ZR
    Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
    Pike DB; Ghandehari H
    Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
    Ding H; Kopecková P; Kopecek J
    J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
    Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
    Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-soluble HPMA copolymer--prostaglandin E1 conjugates containing a cathepsin K sensitive spacer.
    Pan H; Kopecková P; Wang D; Yang J; Miller S; Kopecek J
    J Drug Target; 2006 Jul; 14(6):425-35. PubMed ID: 17092842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery.
    Buckway B; Wang Y; Ray A; Ghandehari H
    Macromol Biosci; 2014 Jan; 14(1):92-9. PubMed ID: 24038924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
    Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1131-48. PubMed ID: 19699249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
    Ríhová B; Kubácková K
    Curr Pharm Biotechnol; 2003 Oct; 4(5):311-22. PubMed ID: 14529421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
    Chytil P; Koziolová E; Etrych T; Ulbrich K
    Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
    Duncan R; Vicent MJ
    Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolytically degradable polymer micelles for drug delivery: a SAXS/SANS kinetic study.
    Filippov SK; Franklin JM; Konarev PV; Chytil P; Etrych T; Bogomolova A; Dyakonova M; Papadakis CM; Radulescu A; Ulbrich K; Stepanek P; Svergun DI
    Biomacromolecules; 2013 Nov; 14(11):4061-70. PubMed ID: 24083567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of a new polymer drug delivery conjugate.
    Christie RJ; Findley DJ; Grainger DW
    Biomed Sci Instrum; 2004; 40():136-41. PubMed ID: 15133948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micelles based on HPMA copolymers.
    Talelli M; Rijcken CJ; van Nostrum CF; Storm G; Hennink WE
    Adv Drug Deliv Rev; 2010 Feb; 62(2):231-9. PubMed ID: 20004693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.
    Koziolová E; Kostka L; Kotrchová L; Šubr V; Konefal R; Nottelet B; Etrych T
    Biomacromolecules; 2018 Oct; 19(10):4003-4013. PubMed ID: 30180562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block copolymers for drug delivery nano systems (DDnSs).
    Kaditi E; Mountrichas G; Pispas S; Demetzos C
    Curr Med Chem; 2012; 19(29):5088-100. PubMed ID: 22963634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
    Lomkova EA; Chytil P; Janoušková O; Mueller T; Lucas H; Filippov SK; Trhlíková O; Aleshunin PA; Skorik YA; Ulbrich K; Etrych T
    Biomacromolecules; 2016 Nov; 17(11):3493-3507. PubMed ID: 27636143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.